Babak Kateb, MD is a neuroscientist with more than 20 years of research experience. His research has been focused on introduction of advance diagnostics and therapeutics into clinical neuroscience in order to rapidly identify and introduce game changing technologies to treat neurological disorders such as brain cancer, Alzheimer’s disease, Parkinson’s disease, and other brain and spinal disorders. Kateb did his educational training at TUSOM, USC, did his research fellowship at USC-keck School of Medicine, Department of Neurosurgery and also studied VLSI system design at USC Department of Electrical Engineering at the Ming Hsieh Institute.
Kateb established the Society for Brain Mapping and Therapeutics (SBMT) while doing his research fellowship 15 years ago at USC. Currently, he is the Founding Chairman of the Board of Directors and CEO Society for Brain Mapping and Therapeutics (SBMT), President and Scientific Director of the Brain Mapping Foundation, and Director of National Center for Nano-Bio-Electronics. The Center is focused on integration of nanotechnology, cellular therapeutics/stem cell, medical device and imaging. Kateb is also a director of Brain Technology & Innovation Park and CEO of Smart Microscopy, Inc.
Kateb was Director of Research and Development in the Department of Neurosurgery at City of Hope Comprehensive Cancer Center where he established collaboration with NASA and published and pioneered the technique for using NASA multiwall carbon nanotubes to activate macrophages for brain cancer immunotherapy. While at City of Hope, he received NASA Tech Brief Award for his pioneering work on sniffing cancer cells using NASA’s electronic nose. In 2010, he joined Department of Neurosurgery at Cedars Sinai Medical Center as a research scientist where he developed partnership between Cedars-Sinai and NASA and established a clinical trial using NASA UV imaging for intraoperative brain mapping. He also patented a technology to microwave brain cancer, which was approved by the FDA for soft tissue; the technology also could be used for brain, liver, head and neck, prostate and breast cancer. He was also Scientific a Director and a Chief Strategy Officer (CSO) at California Neurosurgical Institute from 2015-2017 where he co-authored a nanoneurosurgery paper in Nature-Scientific Reports.
Kateb has been recognized by Vice President Biden, Mayor of Los Angeles, and Governor of California for his dedication in science. He is currently collaborating with Los Alamos National Lab (LANL) and had duel appointments with NASA/JPL as a visiting scientist. His research at NASA and LANL involves the use of Artificial Intelligence (AI), Augmented Reality (AR), Virtual Reality (VR) and supercomputing for brain mapping and therapeutics, and use of LANL advance ultrasonic technology for brain stimulation; he has many patents in these areas. Kateb has established a new publication with PLoSOne, which is called PLoSOne NeuroMapping & Therapeutics, serving as editor-in-chief. He was the force behind three successful NeuroImage-Brain Mapping and Therapeutics special issues. He is the editor of the inaugural Textbook of Nanoneuroscience and Nanoneurosurgery, published by, Taylor & Francis (2013) and the editor of the inaugural Neurophotonic and Brain Mapping (2017).